| atezolizumab based treatment | nivolumab based treatment |
| atezolizumab alone | nivolumab alone |
MIBC - (neo)adjuvant (NA) | | |
MIBC - NA - all population 2 | | |
MIBC - NA - PDL1 positive 1 | | |
Comparator:
vs no additional treatment; vs placebo;
Risk of bias:
low;
some concerns;
high;
NA;